All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for NEURELIS, INC. · Biopharmaceutical company specializing in treatments for neurological conditions.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $10,000.00 income · posted Apr 17, 2026

Official filing document

Bills named in this filing 4

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 7383
RARE Act
S 1214
RARE Act

Lobbying activity 1

Health Issues

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.